Researchers find promising treatment for devastating genetic disorder
2015-07-23
(Press-News.org) A multi-institutional team of researchers has identified an apparently successful treatment for a genetic immune disorder that causes a multitude of health problems - ranging from infections, diabetes, lung disease and the body's immune system attacking and damaging healthy tissues.
Led by Cincinnati Children's Hospital Medical Center and the National Institute of Allergy and Infectious Diseases (NIAID), the researchers report in the July 24 edition of Science a promising therapy for a disorder called LRBA deficiency. They tested the drug abatacept - already FDA-approved for treating rheumatoid arthritis - on a small group of patients whose related health conditions improved following targeted therapy.
"There have been no effective treatments for LRBA deficiency, but this study identifies a therapy that appears to be highly effective at reversing life-threatening infiltrative and autoimmune disease," said Michael Jordan, MD, co-senior investigator on the study and a physician and researcher in the divisions of Immunobiology and Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children's. "The study findings provide a clear rationale for a prospective clinical trial to further test what may be an effective long-term treatment for this disorder."
The research community had a breakthrough with LRBA deficiency in 2012 when the genetic mutations underlying this disorder were first discovered. Discovery of LRBA's disease-causing mutation gave physicians a way to more precisely diagnose patients. Before the mutation was identified, patients were diagnosed with common variable immune deficiency, with no way to successfully manage the disorder's autoimmune complications.
The discovery also allowed researchers at NIAID, Cincinnati Children's and their collaborating institutions to begin detailed studies into LRBA's biological role in helping maintain healthy immune function. Working with clues found in previous studies that describe the underlying molecular processes of the arthritis drug abatacept, the authors focused on a protein in immune cells called CTLA4.
The CTLA4 protein acts as a modulating brake in immune cells. The researchers report that LRBA helps maintain sufficient levels of CTLA4 in regulatory T cells by preventing degradation of the protein.
Regulatory T cells are supposed to provide a self-checking mechanism for the immune system to prevent an excessive response and autoimmunity. When researchers analyzed the regulatory T cells of patients with LRBA deficiency, they noticed significantly lower levels of CTLA4 protein than in the cells of healthy control research subjects who donated cells.
Abatacept treatment works by mimicking the function of CTLA4, helping make up for lower levels of the protein in the immune cells of people with LRBA deficiency. The authors report their data also suggest the plausibility of testing another drug (hydroxychloroquine) as a targeted therapy for LRBA deficiency or other autoimmune disorders linked to reduced levels of CTLA4.
Also collaborating on the current study was co-senior author Michael Lenardo, MD, director of the NIAID Clinical Genomics Program and chief of NIAID's Molecular Development of the Immune System Section. Basic investigation of this disease supported by the National Institutes of Health has justified using abatacept and opens the possibility of hydroxychloroquine as an inexpensive alternative that may work in some patients. This work is an example of how fundamental investigations into the biochemical mechanisms of disease can lead to new treatment concepts.
The study included nine patients, all under age 20, with a range of immune symptoms. Six received treatment with abatacept for a period ranging from six months to eight years. One patient was treated with hydroxychloroquine without abatacept.
The seven treated patients benefitted from treatment and experienced reduced autoimmunity and improved lung function. Researchers said that not all symptoms improved in the patients. Physicians are continuing to investigate how to best apply targeted therapeutic approaches described in the current study to maximize the benefit for patients.
INFORMATION:
Funding support for the study came from an American Society of Hematology Bridge Award, the Cincinnati Children's Hospital Medical Center Gap Award, the divisions of Immunobiology and Bone Marrow Transplantation & Immune Deficiency at Cincinnati Children's, the Intramural Research Program of the NIAID (1ZIAAI000769-14) a grant from the National Institutes of Health (1RC2 HG005608).
About Cincinnati Children's:
Cincinnati Children's Hospital Medical Center ranks third in the nation among all Honor Roll hospitals in U.S. News & World Report's 2014 Best Children's Hospitals. It is also ranked in the top 10 for all 10 pediatric specialties. Cincinnati Children's, a non-profit organization, is one of the top three recipients of pediatric research grants from the National Institutes of Health, and a research and teaching affiliate of the University of Cincinnati College of Medicine. The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education and innovation. Additional information can be found at http://www.cincinnatichildrens.org. Connect on the Cincinnati Children's blog, via Facebook and on Twitter.
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-23
This news release is available in Japanese.
The discovery of a four-legged fossil of a snake hints that this suborder may have evolved from burrowing, rather than marine, ancestors. The unique four-legged specimen, found in Brazil's Crato Formation, provides us with more insight into how these creatures transitioned into the sleek, slithering reptiles that we are familiar with - and often fearful of - today. By analyzing both the genetics and the morphological features of this species compared to other known snake species, and giving different weight to ...
2015-07-23
This news release is available in Japanese.
In the race to produce highly stretchable conductors, researchers have developed a new technique that aligns sheets of layered carbon nanotubes along stretched rubber cores, creating an extremely flexible conductive fiber. From pacemaker leads to flexible displays and batteries, there is a growing need for fibers that don't lose their conductivity upon repeated stretching, twisting or flexing. The challenge has been to create a conductive material that is highly elastic, but that maintains a high level of ...
2015-07-23
Scientists have identified a critical function of what they believe to be schizophrenia's "Rosetta Stone" gene that could hold the key to decoding the function of all genes involved in the disease.
The breakthrough has revealed a vulnerable period in the early stages of the brain's development that researchers hope can be targeted for future efforts in reversing schizophrenia.
In a paper published today in the journal Science, neuroscientists from Cardiff University describe having uncovered the previously unknown influence of a gene in ensuring healthy brain development.
The ...
2015-07-23
COLLEGE PARK, Md. - Do you have gender "faultlines" in your organization? New research suggests that such fissures appear when gender differences solidify into cliques. And this tends to occur when members of one gender share other demographic traits and professional interests, such as age, job responsibilities and time served. For example, the men in one organization might be young techies, while the women might tend to be middle-aged marketers. Or vice versa. What's important is that several qualities align in addition to gender, creating a stronger sense of in-group ...
2015-07-23
ANN ARBOR--A new University of Michigan study finds that teens using marijuana for medical reasons are 10 times more likely to say they are hooked on marijuana than youth who get marijuana illegally.
The study is the first to report on a nationally representative sample of 4,394 high school seniors and their legal or illegal medical marijuana use as it relates to other drug use. In the study, 48 teens had medical marijuana cards, but 266 teens used medical marijuana without a card.
Carol Boyd, the study's lead author and professor at the U-M School of Nursing, said ...
2015-07-23
MADISON, Wis. -- University of Wisconsin-Madison engineers have developed a new approach to structuring the catalysts used in essential reactions in the chemical and energy fields. The advance offers a pathway for industries to wean themselves off of platinum, one of the scarcest metals in the earth's crust.
In an effort to reduce the catalysis world's dependence on this highly reactive and versatile -- but also quite expensive -- metal, UW-Madison chemical engineering Professor Manos Mavrikakis and his collaborators have turned to the nanoscale structure of particles, ...
2015-07-23
MADISON, Wis. -- If you have two working eyes, you are live streaming two images of the world into your brain. Your brain combines the two to produce a view of the world that appears as though you had a single eye -- like the Cyclops from Greek mythology.
And that's a good thing, as the combination of the two images makes for a much more useful impression of the world. With one eye shut, catching a ball or parking a car become far more difficult.
"If you're reaching out with your hand, you want to aim not at where things appear to be, but where they are," says Bas Rokers, ...
2015-07-23
Everybody grieves the death of a loved one, and the process helps most mourners adjust to their loss.
"Charlie Brown was right," said Christopher Layne, a psychologist and researcher at the Semel Institute for Neuroscience and Human Behavior at UCLA. "There is good grief."
But for some people, bereavement becomes a problem in itself, prolonging suffering and impairing functioning. For grieving children and adolescents persistent complex bereavement disorder can derail social and academic development at a time when children and adolescents need to master skills and form ...
2015-07-23
PULLMAN, Wash.--Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother's breast milk.
Michelle McGuire, an associate professor in the WSU School of Biological Sciences, is the lead researcher of the study, the first to have its results independently verified by an accredited, outside organization.
Her findings, presented at the Federation of American Societies for Experimental Biology Conference on July 23 in Big Sky, Mont., show that glyphosate, the most used weed-killing chemical ...
2015-07-23
Sometimes consumers might appreciate a pop-up ad that reflects the merchandise they were recently browsing online, and sometimes they just might decide to spike it and thereafter avoid the seller that placed the ad. Retailers can learn about this behavior in the September 2015 issue of the Journal of Retailing.
In "The Importance of Trust for Personalized Online Advertising," Marketing Professors Alexander Bleier, of Boston College's Carroll School of Management, and Maik Eisenbeiss, of the University of Bremen, show how trust in a particular vendor affects the degree ...
LAST 30 PRESS RELEASES:
[Press-News.org] Researchers find promising treatment for devastating genetic disorder
